Artemisinin News and Research

RSS

Artemisinin is a drug used to treat multi-drug resistant strains of falciparum malaria. The compound (a sesquiterpene lactone) is isolated from the plant Artemisia annua. Not all plants of this species contain artemisinin.

Increased funds lead to 'significant progress' in global malaria fight, WHO report says

WHO's World Malaria Report 2009, which was released on Tuesday, found "increased funding is starting to pay off in the battle against malaria but prevention and treatment must be increased to try to halt the killer disease," Reuters reports (Kelland, 12/15). According to the Associated Press, there were more than 240 million cases of malaria and an estimated 863,000 people, mostly in Africa, died of the disease in 2008 (Cheng, 12/15).

15 Dec 2009

New technological system to help improve availability of anti-malarial drugs in Tanzania

A new solution developed by IBM ( IBM), Novartis and Vodafone with the Roll Back Malaria Partnership, is helping to save lives using everyday technology to improve the availability of anti-malarial drugs in remote areas of Tanzania.

14 Dec 2009

The Hill examines push to get more U.S. funding for malaria medicines

The Hill examines Medicines for Malaria Venture's (MMV) efforts to get more U.S. funding for its work. According to the newspaper, the group is "asking USAID and Congress to redirect more money beginning next year to drug research and development from a pot of funds used to cover the range of efforts to treat and prevent malaria, such as providing mosquito nets."

3 Dec 2009

News outlets examine malaria drug resistance, hope for malaria eradication in Africa

Experts at an American Society of Tropical Medicine and Hygiene meeting this week said that resistance to the best available drug to treat malaria "is more widespread in Southeast Asia than previously reported," Science News/Wired Science reports. Researchers have been monitoring drug resistance along the Thailand-Cambodia border where patients taking artemisinin combination therapy - the most potent treatment for malaria - have been clearing the parasite from their bodies more slowly.

20 Nov 2009

Antimalarial drug resistance endangers malarial control measures

Evidence of resistance to the antimalarial drug artemisinin and its derivatives threatens efforts to control malaria in Southeast Asia, and experts fear artemisinin resistance may spread from the Thailand-Cambodia border to affect other malaria endemic countries. Evidence to such effect was presented today at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).

20 Nov 2009

Malaria experts urge Congress to increase funding for malaria programs

While efforts to control and eliminate malaria have made great strides during the past five years, the looming specter of drug resistance heightens the importance of continued research and development for new tools to assure continued success, according to malaria scientists and public health experts appearing today on Capitol Hill.

19 Nov 2009

TIME examines efforts to combat malaria resistance along Thai-Cambodia border

TIME reports on evidence along the Thai-Cambodia border that the malaria parasite is gaining resistance to artemisinin - "the only remaining effective drug in the world's arsenal against malaria's most deadly strain."

16 Nov 2009

Reuters examines China's involvement in fighting Malaria in Africa

Chinese scientists have been working on enhancing "the rare sweet wormwood shrub, from which artemisinin - the best drug to fight malaria - is derived" in an effort to fight malaria "not on its own soil, where the deadly disease has been sharply pruned back, but in Africa, where it still kills one child every 30 seconds," Reuters reports.

7 Nov 2009

Malaria experts discuss eradication at MIM conference

In a session at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya, experts discussed the tools required to eradicate the disease and highlighted insecticide and drug resistance in some parts of the world, Xinhua reports. Researchers noted that resistance to artemisinin-based combination therapies (ACTs) has been documented in western Cambodia and "has now also been reported in the west of Thailand and in eastern Myanmar," the news service writes (Ooko/Zhuoyun, 11/5).

6 Nov 2009

AMFm subsidized malaria drugs to be delivered soon

Subsidized artemisinin-based combination therapies (ACTs) under the Affordable Medicines Facility - malaria (AMFm) program will be available in select countries "in two week's time," SABC News reports. The announcement came Monday at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya.

4 Nov 2009

Malaria Conference addresses RTS,S vaccine, tools, treatment

On Tuesday at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya, scientists and global health experts focused on malaria eradication, Agence France-Presse reports. "Key among the strategies ... is the development of an effective anti-malaria vaccine, a project scientists have been researching since the late 80s. ... RTS,S is the most clinically advanced malaria vaccine so far, according to the Malaria Vaccine Initiative," the news service writes (11/3).

3 Nov 2009

Opinions: Obstetric fistula; malaria and climate change

In a New York Times opinion piece, columnist Nicholas Kristof examines a new plan to tackle obstetric fistula, "a childbirth injury, often suffered by a teenager in Africa or Asia whose pelvis is not fully grown." According to Kristof, "Just about the happiest thing that can happen to such a woman is an encounter with Dr. Lewis Wall, an ob-gyn at Washington University in St. Louis.

3 Nov 2009

ACTwatch data indicates low accessibility of artemisinin combination therapy

ACTwatch, a research project led by PSI, in collaboration with the London School of Hygiene and Tropical Medicine, released evidence today that indicates that artemisinin combination therapy, the most effective medicines for treating malaria, continue to have a significantly low presence on the market among populations considered to be most at risk.

2 Nov 2009

Also in Global Health News: Ghana, Nigeria Global Fund grants; CDC Director on global health role; African Peacekeepers and HIV/AIDS

Stabroek News reports on the recent news that Guyana received a $10 million grant from the Global Fund to Fight AIDS, Tuberculosis and Malaria. The "six-year programme aims at strengthening critical areas in the system such as Mental Health; the Nursing Programme; Management and Development Programme; Surveillance and Monitoring Programme and Management and Information systems," the newspaper writes (10/23).

26 Oct 2009

Recent releases in Global Health

A Lancet comment examines an Affordable Medicines Facility for malaria (AMFm) program to help countries procure subsidized artemisinin-based combination treatments (ACTs).

9 Oct 2009

WHO Asia-Pacific Countries pledge to use artemisinin with other drugs by 2015 to prevent drug-resistance

On Wednesday, nine of the 10 countries in the WHO's Asia-Pacific region "that suffer most" from malaria pledged to phase out the use of artemisinin-only to treat malaria and use it in combination with other drugs by 2015, Reuters reports (Lyn, 9/23).

28 Sep 2009

Six research project grants aimed at improving human health awarded

Six research project grant awards totaling $5.1 million will be made to Washington life sciences organizations and their partners, the state’s Life Sciences Discovery Fund announced today.

16 Sep 2009

Campaign seeks to distribute 700m bednets in sub-Saharan Africa by 2015

Several organization led by the WHO have contributed $5 billion for a campaign aimed at distributing 700 million bednets to prevent malaria in sub-Saharan Africa by 2015, the East African reports.

9 Sep 2009

Ghana seeks to eliminate malaria

In October, Ghana's Ministry of Health plans to begin a national program to eliminate malaria with the goal of being the first country in Africa to eradicate the disease, George Sipa-Adjah Yankey, the minister of health, said recently at the 74th Annual Conference of the Pharmaceutical Society of Ghana in Accra, Ghana, GNA/Homepage Ghana reports. Yankey cited the looming threat of the malaria parasite's resistance to artemisinin therapy (8/3).

5 Aug 2009

Malaria: Artemisinin resistance continues developing in western Cambodia

Artemisinin, the "basis of the most effective" malaria treatment recommended by the WHO, took nearly twice as long to clear malaria parasites in patients in western Cambodia than it did in patients in northwestern Thailand, according to a New England Journal of Medicine study, which shows the "drugs are losing their power against the disease in Cambodia," Bloomberg reports (Bennett, 7/30).

30 Jul 2009